Patients With Refractory, Metastatic Cancer Harboring KIT Mutation or Amplification to Investigate the Clinical Efficacy and Safety of Imatinib Therapy
Clinical trial NCT02461849 · UNKNOWN
Trial details
- NCT number
- NCT02461849
- Sponsor
- Samsung Medical Center
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-04
- Primary completion
- 2022-06-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.